Unilever's Defensive Split Could Free Up Capital for Growth—But Time Is Ticking

Unilever is preparing to execute a major corporate restructuring, but the move is less about ambition and more about defense. The company is in talks to separate its food business in a deal that would combine it with spice maker McCormick, potentially finalizing the transaction by the end of the month. The structure would be a Reverse Morris Trust, a tax-efficient mechanism designed for such spin-offs. This isn't a growth play; it's a strategic retreat from a segment under severe pressure.

The core driver is weak demand. Major food companies like Unilever and Nestlé are struggling as budget-conscious consumers cut back on spending and opt for cheaper store brands. The trend is being amplified by the rising adoption of GLP-1 weight-loss drugs, which curb overall consumption and shift consumer preferences toward less calorie-dense products. In this environment, the food business is a drag. The proposed separation is a direct response, allowing Unilever to shed a struggling unit and focus its capital and management attention on its higher-growth beauty and personal-care portfolio.

This defensive split echoes a well-worn historical playbook. Activist investors have long pushed for conglomerate splits, arguing that distinct businesses need different strategies and capital allocations. The most relevant parallel is the merger and eventual separation of chemical giants Dow and Dupont, orchestrated by activist Nelson Peltz's firm. In that case, the split unlocked value by allowing each company to pursue its own path. Unilever's activist board member, Peltz, has a similar track record of pushing for corporate reconfigurations, lending credibility to the argument that separation is the best path forward for the remaining portfolio.

The thesis here is clear: the move is defensive, but its ultimate success hinges on the remaining company's ability to generate growth. By spinning off food, Unilever is betting that its beauty and home business can justify the capital reallocation. The historical precedent suggests the structure can work, but it only works if the remaining entity can execute. The pressure is now on Unilever's leadership to prove that a leaner, focused portfolio can drive value in a challenging consumer landscape.

The Valuation Challenge: OpenAI's Path to Public Markets

OpenAI is preparing for a public debut that would test the limits of what markets will pay for pure growth. The company is now laser-focused on transforming its 900 million weekly active users into high-compute enterprise customers, a pivot that is central to justifying its astronomical valuation. This strategy mirrors a critical phase in the IPO journeys of past tech giants, where scaling a consumer base into profitable enterprise revenue was the make-or-break step.

The scale of the ambition is historic. OpenAI is on the verge of a funding round that could value it at over $850 billion, the largest private raise in history. This massive capital infusion is meant to fuel the compute infrastructure needed to serve enterprise clients, but it also sets an incredibly high bar. The company's own projections show a path to $280 billion in revenue by 2030, with enterprise and consumer businesses each contributing roughly half. The challenge is to convert user volume into the high-margin, recurring revenue streams that justify a premium valuation.

The historical parallel is clear. When Salesforce went public in 2004, its valuation was built on the promise of enterprise software adoption, not just user numbers. OpenAI is attempting the same leap today, but with a more complex and costly technology stack. The company has already signaled urgency, declaring a "code red" last December to improve its product and pulling back on other investments to focus on the core AI race. The recent shift in its compute spending target-from a $1.4 trillion figure to a more targeted $600 billion by 2030-shows an effort to manage expectations and tie massive capital expenditure directly to projected revenue growth.

The bottom line is that OpenAI's strategy is necessary, but it may not be sufficient. The company must execute flawlessly to turn its vast user base into a high-compute enterprise engine. Any stumble in this transition would directly challenge the valuation built on years of future revenue. For now, the IPO path is set, but the real test begins when the company must prove it can deliver on that promise to public investors.

Catalysts, Risks, and What to Watch

The strategic paths for Unilever and OpenAI now hinge on specific near-term events and the risks that could derail them. For investors, the coming weeks offer a clear framework to assess the validity of each plan.

For Unilever, the primary catalyst is the outcome of its food business talks. The deal, which could be finalized by the end of the month, is the immediate test of its defensive split strategy. The company's pivot to beauty and wellbeing depends on this transaction executing smoothly. The key risk is that the food business's value is overstated if weak consumer demand persists. Evidence shows budget-conscious consumers cut back on spending and opt for cheaper store brands, a trend amplified by weight-loss drugs. If this demand slump continues, the combined entity's valuation could be challenged, undermining the rationale for the separation.

OpenAI's catalyst is its potential public debut. The company is preparing for an IPO, with the exact timing still subject to change but a potential IPO by the end of the year cited as a possibility. The focus is now squarely on converting its massive user base into enterprise revenue. The key risk here is intense competition in the enterprise AI market. Rivals like Google and Anthropic are aggressively pushing their own offerings, with Anthropic making a direct push for business deals. OpenAI's own leadership has signaled urgency, declaring a "code red" last December to improve its product and pull back on other investments. Any stumble in capturing enterprise market share would directly challenge the valuation built on future revenue.

In both cases, investors should monitor official statements from the companies for confirmation or changes to the plans. For Unilever, watch for signs of demand recovery in the consumer staples sector, which would validate or invalidate the core premise of the split. For OpenAI, the critical signal will be trends in enterprise AI adoption, not just user numbers. The company's CFO is building a finance team ahead of a market debut, indicating the focus is shifting from growth to the financial discipline required for public scrutiny. The coming months will test whether these strategic bets can withstand the pressures of their respective markets.